FTCI
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 19 | -4 | 980.89K | $4.98M | +1 | −5 |
| Q1 2026 | 23 | -6 | 1.20M | $4.53M | +3 | −9 |
| Q4 2025 | 29 | +1 | 1.32M | $14.40M | +2 | −1 |
| Q3 2025 | 9 | 0 | 664.71K | $4.69M | +1 | −1 |
| Q2 2025 | 6 | 0 | 518.09K | $2.35M | n/a | n/a |
| Q1 2025 | 4 | +1 | 166.65K | $478,334 | +1 | n/a |
| Q4 2024 | 3 | -2 | 186.51K | $1.03M | n/a | −2 |
| Q3 2024 | 4 | -2 | 1.91M | $1.30M | n/a | −2 |
| Q2 2024 | 6 | n/a | 3.31M | $1.17M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 925.76K | -37.8% | $630,074 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 766.86K | +9.2% | $522,039 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Citadel Advisors ✦ | 145.61K | -4.7% | $99,100 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | T. Rowe Price ✦ | 68.10K | 0.0% | $47,000 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Point72 Asset Management | $254,104 | was 0.0% |
| AQR Capital Management | $61,783 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 38 holders, 1.58M shares, $5.56M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 101.08K sh @ 2.69 · $271,913
Director · 39.58K sh @ 2.35 · $93,020
Director · 33.29K sh @ 2.19 · $72,905
Officer, Director · Chief Executive… · 24.75K sh @ 2.08 · $51,470
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology